- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — JV/Acquisition, 23-05-2025: Acquisition
23-05-2025 | 05:50 pm
23-05-2025 | 05:50 pm
Lupin Inc. USA has converted a USD 44.3 million loan to Lupin Oncology Inc. into equity, increasing its stake in LOI to 99.87%, making it a step-down subsidiary. LOI, focused on oncology product development and commercialization in the US, currently has a net worth of USD 7 million but no revenue. This move deepens Lupin’s presence in the US oncology market and bolsters its product pipeline, giving Lupin greater operational control without immediate financial impact.
No comments yet. Be the first to comment!